Update in molecular diagnostics in melanocytic neoplasms

Area of Science:

• Dermatopathology
• Oncology
• Genetics

Background:

• Melanocytic neoplasms classification is evolving with the integration of molecular data.
• Gene mutations and chromosomal copy number aberrations are linked to clinical and morphological features.
• Familial melanoma syndromes and somatic mutations are key areas of research.

Purpose of the Study:

• To review recent advances in molecular aberrations in melanocytic neoplasms.
• To correlate molecular findings with clinical, morphological, and prognostic implications.
• To discuss current molecular diagnostic techniques and future directions.

Main Methods:

• Review of recent scientific literature on molecular aberrations in melanocytic neoplasms.
• Analysis of familial germline mutations (e.g., BRCA1-associated protein-1 familial melanoma syndrome).
• Discussion of somatic mutations, chromosomal copy number aberrations, and fluorescence in situ hybridization (FISH) assays.

Main Results:

• Specific molecular aberrations correlate with distinct clinical and morphological features.
• Molecular diagnostics offer improved prognostic information for melanocytic neoplasms.
• Fluorescence in situ hybridization (FISH) for 9p21 is valuable in spitzoid neoplasms.

Conclusions:

• Molecular aberrations are crucial for future classification systems of melanocytic neoplasms.
• Understanding these aberrations enhances diagnostic accuracy, prognostic assessment, and therapeutic strategies.
• Paradoxical activation of wild-type BRAF in vemurafenib-treated patients warrants further clinical investigation.